309 related articles for article (PubMed ID: 31609493)
1. Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon.
Zorron Cheng Tao Pu L; Yamamoto K; Honda T; Nakamura M; Yamamura T; Hattori S; Burt AD; Singh R; Hirooka Y; Fujishiro M
J Gastroenterol Hepatol; 2020 Mar; 35(3):433-437. PubMed ID: 31609493
[TBL] [Abstract][Full Text] [Related]
2. Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer.
Ohashi A; Yamamura T; Nakamura M; Maeda K; Sawada T; Ishikawa E; Yamamoto K; Ishikawa T; Kakushima N; Furukawa K; Ohno E; Honda T; Kawashima H; Ishigami M; Fujishiro M
Digestion; 2022; 103(6):451-461. PubMed ID: 36349755
[TBL] [Abstract][Full Text] [Related]
3. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
4. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
5. Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
Oncol Rep; 2016 Jan; 35(1):325-33. PubMed ID: 26549775
[TBL] [Abstract][Full Text] [Related]
6. Enterotype-based Analysis of Gut Microbiota along the Conventional Adenoma-Carcinoma Colorectal Cancer Pathway.
Yang TW; Lee WH; Tu SJ; Huang WC; Chen HM; Sun TH; Tsai MC; Wang CC; Chen HY; Huang CC; Shiu BH; Yang TL; Huang HT; Chou YP; Chou CH; Huang YR; Sun YR; Liang C; Lin FM; Ho SY; Chen WL; Yang SF; Ueng KC; Huang HD; Huang CN; Jong YJ; Lin CC
Sci Rep; 2019 Jul; 9(1):10923. PubMed ID: 31358825
[TBL] [Abstract][Full Text] [Related]
7. Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer.
Yao Q; Tang M; Zeng L; Chu Z; Sheng H; Zhang Y; Zhou Y; Zhang H; Jiang H; Ye M
BMC Microbiol; 2021 May; 21(1):156. PubMed ID: 34044781
[TBL] [Abstract][Full Text] [Related]
8. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
[TBL] [Abstract][Full Text] [Related]
9. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
[TBL] [Abstract][Full Text] [Related]
10. The multispecies microbial cluster of Fusobacterium, Parvimonas, Bacteroides and Faecalibacterium as a precision biomarker for colorectal cancer diagnosis.
Conde-Pérez K; Aja-Macaya P; Buetas E; Trigo-Tasende N; Nasser-Ali M; Rumbo-Feal S; Nión P; Arribas EM; Estévez LS; Otero-Alén B; Noguera JF; Concha Á; Pardiñas-López S; Carda-Diéguez M; Gómez-Randulfe I; Martínez-Lago N; Ladra S; Aparicio LMA; Bou G; Mira Á; Vallejo JA; Poza M
Mol Oncol; 2024 May; 18(5):1093-1122. PubMed ID: 38366793
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium and colorectal cancer: causal factor or passenger? Results from a large colorectal cancer screening study.
Amitay EL; Werner S; Vital M; Pieper DH; Höfler D; Gierse IJ; Butt J; Balavarca Y; Cuk K; Brenner H
Carcinogenesis; 2017 Aug; 38(8):781-788. PubMed ID: 28582482
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea.
Kim M; Lee ST; Choi S; Lee H; Kwon SS; Byun JH; Kim YA; Rhee KJ; Choi JR; Kim TI; Lee K
Sci Rep; 2020 Nov; 10(1):19915. PubMed ID: 33199749
[TBL] [Abstract][Full Text] [Related]
13. Enrichment of Prevotella intermedia in human colorectal cancer and its additive effects with Fusobacterium nucleatum on the malignant transformation of colorectal adenomas.
Lo CH; Wu DC; Jao SW; Wu CC; Lin CY; Chuang CH; Lin YB; Chen CH; Chen YT; Chen JH; Hsiao KH; Chen YJ; Chen YT; Wang JY; Li LH
J Biomed Sci; 2022 Oct; 29(1):88. PubMed ID: 36303164
[TBL] [Abstract][Full Text] [Related]
14. Tumour-associated and non-tumour-associated microbiota: Addendum.
Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW
Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132
[TBL] [Abstract][Full Text] [Related]
15. Association of oncogenic bacteria with colorectal cancer in South China.
Zhou Y; He H; Xu H; Li Y; Li Z; Du Y; He J; Zhou Y; Wang H; Nie Y
Oncotarget; 2016 Dec; 7(49):80794-80802. PubMed ID: 27821805
[TBL] [Abstract][Full Text] [Related]
16. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
Kwong TNY; Wang X; Nakatsu G; Chow TC; Tipoe T; Dai RZW; Tsoi KKK; Wong MCS; Tse G; Chan MTV; Chan FKL; Ng SC; Wu JCY; Wu WKK; Yu J; Sung JJY; Wong SH
Gastroenterology; 2018 Aug; 155(2):383-390.e8. PubMed ID: 29729257
[TBL] [Abstract][Full Text] [Related]
17. Mucosa-associated microbiota signature in colorectal cancer.
Gao R; Kong C; Huang L; Li H; Qu X; Liu Z; Lan P; Wang J; Qin H
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2073-2083. PubMed ID: 28600626
[TBL] [Abstract][Full Text] [Related]
18. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
19.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
20. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer.
Huh JW; Kim MJ; Kim J; Lee HG; Ryoo SB; Ku JL; Jeong SY; Park KJ; Kim D; Kim JF; Park JW
Microbiome; 2022 Nov; 10(1):203. PubMed ID: 36443754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
